Novel Use Of Hydroxyurea in an African Region With Malaria
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 30 Mar 2017
At a glance
- Drugs Hydroxycarbamide (Primary)
- Indications Sickle cell anaemia
- Focus Therapeutic Use
- Acronyms NOHARM
- 07 Jun 2017 Biomarkers information updated
- 22 Mar 2017 Planned End Date changed from 1 Dec 2017 to 1 Oct 2017.
- 25 Jun 2016 Status changed from recruiting to active, no longer recruiting.